DK130393D0 - 3-trifluormethylsulfonatsteroidderivat - Google Patents

3-trifluormethylsulfonatsteroidderivat

Info

Publication number
DK130393D0
DK130393D0 DK931303A DK130393A DK130393D0 DK 130393 D0 DK130393 D0 DK 130393D0 DK 931303 A DK931303 A DK 931303A DK 130393 A DK130393 A DK 130393A DK 130393 D0 DK130393 D0 DK 130393D0
Authority
DK
Denmark
Prior art keywords
beta
alpha
trifluoromethylsulphonate
steroid derivative
preparation
Prior art date
Application number
DK931303A
Other languages
English (en)
Other versions
DK169787B1 (da
DK130393A (da
Inventor
Dennis Alan Holt
Mark Alan Levy
Brian Walter Metcalf
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK130393D0 publication Critical patent/DK130393D0/da
Publication of DK130393A publication Critical patent/DK130393A/da
Application granted granted Critical
Publication of DK169787B1 publication Critical patent/DK169787B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK130393A 1988-05-25 1993-11-19 3-trifluormethylsulfonatsteroidderivater DK169787B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19853488A 1988-05-25 1988-05-25
US19853488 1988-05-25

Publications (3)

Publication Number Publication Date
DK130393D0 true DK130393D0 (da) 1993-11-19
DK130393A DK130393A (da) 1993-11-19
DK169787B1 DK169787B1 (da) 1995-02-27

Family

ID=22733779

Family Applications (2)

Application Number Title Priority Date Filing Date
DK279790A DK168295B1 (da) 1988-05-25 1990-11-23 Østrananalog forbindelse, farmaceutisk middel indeholdende forbindelsen samt anvendelse af forbindelsen ved fremstilling af et lægemiddel til inhibering af steroid-5-alfa-reduktaseaktivitet
DK130393A DK169787B1 (da) 1988-05-25 1993-11-19 3-trifluormethylsulfonatsteroidderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK279790A DK168295B1 (da) 1988-05-25 1990-11-23 Østrananalog forbindelse, farmaceutisk middel indeholdende forbindelsen samt anvendelse af forbindelsen ved fremstilling af et lægemiddel til inhibering af steroid-5-alfa-reduktaseaktivitet

Country Status (15)

Country Link
EP (1) EP0343954B1 (da)
JP (1) JP2675418B2 (da)
AT (1) ATE114665T1 (da)
AU (1) AU627466B2 (da)
CA (1) CA1331457C (da)
DE (1) DE68919537T2 (da)
DK (2) DK168295B1 (da)
ES (1) ES2065378T3 (da)
GR (1) GR3015135T3 (da)
IE (1) IE68858B1 (da)
IL (1) IL91968A (da)
NO (1) NO174964C (da)
PT (1) PT90656B (da)
WO (1) WO1989011282A1 (da)
ZA (1) ZA893971B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138063A (en) * 1984-02-27 1992-08-11 Merck & Co., Inc. 17β-methoxycarbonyl-4-aza-androsten-1-en-3-ones
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5098908A (en) * 1990-06-20 1992-03-24 Merck & Co., Inc. 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors
US5151430A (en) * 1990-06-20 1992-09-29 Merck & Co., Inc. Specific 17β-thiobenzoyl-4-aza-5α-androst-1-en-3-ones as antiandrogen agents
US5162332A (en) * 1990-06-20 1992-11-10 Merck & Co., Inc. Selected 17 β-polyaroyl-4-aza-5 α-androst-1-en-3-ones as steroidal reductase inhibitors
US5061802A (en) * 1990-06-20 1991-10-29 Merck & Co. Inc. 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
IL101243A (en) * 1991-03-20 1999-12-22 Merck & Co Inc Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history
FI945105A7 (fi) * 1992-04-30 1994-10-31 Smithkline Beecham Corp 17alfa- ja 17beta-substituoitu estra-1,3,5(10)-trieeni-3-karboksyyliha ppo
ES2149208T3 (es) * 1992-05-20 2000-11-01 Merck & Co Inc Inhibidores 4-azaesteroides de 5-alfa-reductasa.
US5610162A (en) * 1992-05-20 1997-03-11 Merck & Co., Inc. Ester derivatives of 4-aza-steroids
US5237064A (en) * 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
CA2135057A1 (en) * 1992-05-20 1993-11-25 Bruce E. Witzel 17-amino substituted 4-azasteroid 5a-reductase inhibitors
ES2148229T3 (es) * 1992-05-20 2000-10-16 Merck & Co Inc Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
HUT71484A (en) * 1992-05-20 1995-11-28 Merck & Co Inc Process for producing of 7beta-substituted-4-aza-5alpha-cholestan-ones as 5-alpha-reductase inhibitors and pharmaceuticals compositions containing them
US5324734A (en) * 1992-09-15 1994-06-28 Merck & Co., Inc. Oxidization metabolites of 5-α-23-methyl-4-aza-21-nor-chol-1-ene-3, 20-dione
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5359071A (en) * 1993-03-12 1994-10-25 Merck & Co., Inc. 15-substituted 4-azasteroids
WO1994021614A1 (en) * 1993-03-24 1994-09-29 Merck & Co., Inc. SUBSTITUTED 3-PHENANTHRIDINONE DERIVATIVES AS 5α-REDUCTASE INHIBITORS
WO1995000147A1 (en) * 1993-06-28 1995-01-05 Merck & Co., Inc. 4-AZA-PREGNANE 5α-REDUCTASE ISOZYME 1 INHIBITORS
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5430157A (en) * 1993-12-13 1995-07-04 Eli Lilly And Company Reduced phenanthrenes
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1107664B (de) * 1959-11-05 1961-05-31 Schering Ag Verfahren zur Herstellung neuer in 3-Stellung substituierter OEstratriene
US3622670A (en) * 1969-08-22 1971-11-23 American Home Prod Method of inducing ovulation
US4185101A (en) * 1977-08-11 1980-01-22 Schering Corporation 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4340602A (en) * 1978-10-18 1982-07-20 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors

Also Published As

Publication number Publication date
DE68919537T2 (de) 1995-05-11
ZA893971B (en) 1990-05-30
GR3015135T3 (en) 1995-05-31
DK279790A (da) 1990-11-23
HK1006461A1 (en) 1999-02-26
EP0343954A3 (en) 1990-05-16
CA1331457C (en) 1994-08-16
DE68919537D1 (de) 1995-01-12
PT90656A (pt) 1989-11-30
PT90656B (pt) 1994-10-31
AU3748789A (en) 1989-12-12
NO894065L (no) 1991-04-12
EP0343954A2 (en) 1989-11-29
IL91968A (en) 1994-10-21
NO894065D0 (no) 1989-10-11
ATE114665T1 (de) 1994-12-15
DK169787B1 (da) 1995-02-27
DK130393A (da) 1993-11-19
IE68858B1 (en) 1996-07-24
JPH03504498A (ja) 1991-10-03
IE891732L (en) 1989-11-25
NO174964C (no) 1994-08-10
AU627466B2 (en) 1992-08-27
ES2065378T3 (es) 1995-02-16
WO1989011282A1 (en) 1989-11-30
DK168295B1 (da) 1994-03-07
JP2675418B2 (ja) 1997-11-12
EP0343954B1 (en) 1994-11-30
NO174964B (no) 1994-05-02
DK279790D0 (da) 1990-11-23

Similar Documents

Publication Publication Date Title
DK130393D0 (da) 3-trifluormethylsulfonatsteroidderivat
ATE118505T1 (de) Phosphinsäure-derivate von aromatischen steroiden als 5-alpha reduktase-inhibitoren.
DE68919660D1 (de) Phosphonsäure-Derivate von aromatischen Steroiden als 5-alpha-Reduktase-Inhibitoren.
AU4257889A (en) Sulphonamido-phenylalkanoic acid derivatives having thromboxane A2 antagonist activity
AU2960292A (en) Intermediates useful in the preparation of sulfonic acid substituted aromatic A ring analogues of steroidal synthetic compounds
ATE104665T1 (de) Chinazolinon-derivate.
SE8804036D0 (sv) New use of 11,28-dioxa-4-azatricyclo(22.3.1.0?724,9 )octacos-18-ene derivatives and pharmaceutical compositions containing them
ATE94535T1 (de) 4-amino-3-acylchinolin-derivate und ihre verwendung als inhibitoren der magensekretion.
ES8707496A1 (es) Un procedimiento para preparar derivados de azetidinona
NO895252L (no) Karboksimidamid-derivater.
ES8200364A1 (es) Procedimiento para la obtencion de derivados de la fenotia- zina
GB1471546A (en) 1-acyl-4-substituted alkyl-piperazine or homopiperazine derivatives nad process for preparation thereof

Legal Events

Date Code Title Description
A0 Application filed